{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:15:25Z","timestamp":1785842125615,"version":"3.56.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.annepidem.2010.10.002","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T04:49:59Z","timestamp":1292474999000},"page":"188-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Contraception Methods, Beyond Oral Contraceptives and Tubal Ligation, and Risk of Ovarian Cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"Roberta B.","family":"Ness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhiannon C.","family":"Dodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten B.","family":"Moysich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2010.10.002_bib1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJM198703123161102","article-title":"The reduction in risk of ovarian cancer associated with oral contraceptives use","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2010.10.002_bib2","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women","volume":"136","author":"Whittemore","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2010.10.002_bib3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ijc.2910620606","article-title":"Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women\u2019s Health Study Group","volume":"62","author":"Purdie","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.annepidem.2010.10.002_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/aje\/152.3.233","article-title":"Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives","volume":"152","author":"Ness","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2010.10.002_bib5","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1001\/jama.1993.03510230051034","article-title":"Tubal ligation, hysterectomy, and risk of ovarian cancer: a prospective study","volume":"270","author":"Hankinson","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2010.10.002_bib6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/oxfordjournals.aje.a009112","article-title":"Tubal ligation and fatal ovarian cancer in a large prospective cohort study","volume":"145","author":"Miracle-McMahill","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2010.10.002_bib7","first-page":"933","article-title":"Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives","volume":"5","author":"Rosenblatt","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.annepidem.2010.10.002_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/ije\/dyh046","article-title":"Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A\u00a0Danish population-based follow-up study of more than 65 000 sterilized women","volume":"33","author":"Kjaer","year":"2004","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.annepidem.2010.10.002_bib9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer","volume":"339","author":"Narod","year":"1998","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.annepidem.2010.10.002_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1158\/1055-9965.EPI-08-0546","article-title":"Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1\/2 Carrier Cohort Study","volume":"18","author":"Antoniou","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.annepidem.2010.10.002_bib11","first-page":"439","article-title":"Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)","volume":"14","author":"Modugno","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.annepidem.2010.10.002_bib12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0277-5379(91)90226-4","article-title":"Oral contraceptive use and the risk of ovarian cancer: an Italian case-control study","volume":"27","author":"Parazzini","year":"1991","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annepidem.2010.10.002_bib13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/bjc.1989.320","article-title":"Risk factors for ovarian cancer: a case-control study","volume":"60","author":"Booth","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.annepidem.2010.10.002_bib14","first-page":"3658","article-title":"Reproductive factors of ovarian and endometrial cancer risk in high fertility population in Mexico","volume":"59","author":"Salazar-Martinez","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.annepidem.2010.10.002_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001648-200105000-00010","article-title":"Oral contraceptives, other methods of contraception and risk reduction for ovarian cancer","volume":"12","author":"Ness","year":"2001","journal-title":"Epidemiology"},{"key":"10.1016\/j.annepidem.2010.10.002_bib16","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/aje\/kwm157","article-title":"Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk","volume":"166","author":"Tworoger","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2010.10.002_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/oxfordjournals.epirev.a017983","article-title":"Fertility drugs and ovarian cancer","volume":"20","author":"Glud","year":"1998","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.annepidem.2010.10.002_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/aje\/155.3.217","article-title":"Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies","volume":"155","author":"Ness","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2010.10.002_bib19","first-page":"335","article-title":"Cancer risk among users of oral contraceptives: Cohort data from the Royal College of General Practitioner\u2019s oral contraception study","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.annepidem.2010.10.002_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: Collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2010.10.002_bib21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0010-7824(91)90003-X","article-title":"Oral contraceptives and neoplasia of the ovary","volume":"43","author":"Stanford","year":"1991","journal-title":"Contraception"},{"issue":"124","key":"10.1016\/j.annepidem.2010.10.002_bib22","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/ijc.24232","article-title":"Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006","volume":"15","author":"Dorjgochoo","year":"2009","journal-title":"Int J\u00a0Cancer"},{"key":"10.1016\/j.annepidem.2010.10.002_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation \u2013 a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2010.10.002_bib24","first-page":"717","article-title":"Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis","volume":"71","author":"Cramer","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.annepidem.2010.10.002_bib25","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of adrogens and progesterone","volume":"90","author":"Risch","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.annepidem.2010.10.002_bib26","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","article-title":"Possible role of ovarian epithelial inflammation in ovarian cancer","volume":"91","author":"Ness","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.annepidem.2010.10.002_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00001648-200003000-00006","article-title":"Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer","volume":"11","author":"Ness","year":"2000","journal-title":"Epidemiology"},{"key":"10.1016\/j.annepidem.2010.10.002_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/1047-2797(94)00098-E","article-title":"Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer","volume":"5","author":"Cramer","year":"1995","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.annepidem.2010.10.002_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ogc.2007.02.004","article-title":"Intrauterine contraception: the pendulum swings back","volume":"34","author":"MacIsaac","year":"2007","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.annepidem.2010.10.002_bib30","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/oxfordjournals.aje.a117563","article-title":"Recall accuracy for prescription medications: self-report compared with database information","volume":"142","author":"West","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2010.10.002_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0010-7824(86)90079-X","article-title":"The ability of women to recall their oral contraceptive histories","volume":"33","author":"Coulter","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.annepidem.2010.10.002_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.aje.a115129","article-title":"The agreement between questionnaire data and medical records: the evidence of accuracy of recall","volume":"129","author":"Harlow","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2010.10.002_bib33","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/ije\/22.4.692","article-title":"Validity of contraceptive histories in a rural community in Kenya","volume":"22","author":"Maggwa","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.annepidem.2010.10.002_bib34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/oxfordjournals.aje.a112529","article-title":"Agreement rates between oral contraceptive users and prescribers in relation to drug use histories","volume":"107","author":"Stolley","year":"1978","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2010.10.002_bib35","first-page":"921","article-title":"Use of life calendar to enhance the quality of exposure and risk factors histories","volume":"128","author":"Wingo","year":"1988","journal-title":"Am J Epidemiol"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104727971000356X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104727971000356X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:09:04Z","timestamp":1760926144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104727971000356X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S104727971000356X"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2010.10.002","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraception Methods, Beyond Oral Contraceptives and Tubal Ligation, and Risk of Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2010.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}